Udayavni Special

Covid-19 plasma therapy shows little benefit in patients in India: Study


PTI, Oct 23, 2020, 5:20 PM IST

New Delhi: Convalescent plasma therapy, which uses the blood of recovered Covid-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The study, published in the British Medical Journal (BMJ) involved 464 adults with moderate Covid-19 who were admitted to hospitals in India between April and July.

As many as 239 adult patients received two transfusions of convalescent plasma, 24 hours apart, alongside standard care, while the control group comprising of 229 patients received standard care only.

One month later, 44 patients or 19 per cent of those who received the plasma had progressed to severe disease or had died of any cause, compared with 41 patients or 18 per cent in the control group.

Plasma therapy did, however, seem to reduce symptoms, such as shortness of breath and fatigue, after seven days, according to the researchers, including those from the Indian Council of Medical Research (ICMR), and National Institute of Epidemiology, Tamil Nadu.

“Convalescent plasma was not associated with a reduction in progression to severe Covid-19 or all-cause mortality,” the researchers wrote in the journal.

“This trial has high generalisability and approximates convalescent plasma use in real-life settings with limited laboratory capacity,” they said.

The researchers noted that a prior measurement of neutralising antibody titres in donors and participants might further clarify the role of convalescent plasma in the management of Covid-19.

Patients in the study were aged at least 18 years who had confirmed Covid-19 based on a RT-PCR result for SARS-CoV-2, the virus that causes the disease.

Participants in the intervention arm received two doses of 200 milliliter (mL) of convalescent plasma, transfused 24 hours apart, in addition to the best standard of care.

Although the observational studies conducted previously suggested clinical benefits in recipients of convalescent plasma, the trials were stopped early and failed to ascertain any mortality benefit from plasma treatment in patients with Covid-19, the researchers said.

The new study shows that in settings with limited laboratory capacity, convalescent plasma does not reduce 28 day mortality or progression to severe disease in patients admitted to hospital with moderate Covid-19, they said.

Although plasma treatment was associated with earlier resolution of shortness of breath and fatigue and higher negative conversion of SARS-CoV-2 RNA on day 7 of enrolment, as a potential treatment for patients with moderate Covid-19 it showed limited effectiveness

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Shivamogga: After attack on Bajrang Dal worker, situation remains tense

Domestic flights allowed at 80% of pre-covid levels from today: Centre

NCB suspends 2 IOs for no show in court in Bharti Singh case

Ex-Punjab CM Parkash Singh Badal returns Padma award over farm laws

Kerala CM calls for high-level meeting to tackle rain fury

Criminal networks could try to sell fake COVID vaccines physically and on internet, warns Interpol

Board exams: CISCE writes to all CMs to allow partial reopening of schools from Jan for class 10, 12



Related Articles More

5 Covid-19 Vaccines Undergoing Trial in India Logistically Feasible for Distribution in Both Urban, Rural Areas: AIIMS Director

Farmers demand farm commission as they threaten to intensify protest against farm laws

Domestic flights allowed at 80% of pre-covid levels from today: Centre

Akhtar submits statement in defamation plaint against Kangana

NCB suspends 2 IOs for no show in court in Bharti Singh case

MUST WATCH

Pro-terror graffiti case culprits will be arrested soon: Basavaraj Bommai

Meal of Bakasur : Hotel Fish Campus Udupi | Udayavani

Things You Should Know When Starting A Business | Profitable Business Ideas After Lockdown

Mangalore Boat tragedy: We’re with families of deceased, says Kota after announcing Rs 6 lakh compensation

Mangaluru boat tragedy: Body of another fisherman recovered

Latest Additions

5 Covid-19 Vaccines Undergoing Trial in India Logistically Feasible for Distribution in Both Urban, Rural Areas: AIIMS Director

More than 1 lakh people already vaccinated against COVID-19: Russia

Hotel Association of India launches Karnataka chapter

Shivamogga: After attack on Bajrang Dal worker, situation remains tense

Amazon is one of the biggest threats to the fashion industry: Christopher Wylie, Cambridge Analytica whistleblower

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.